Do the extra pounds return after the diet? This intestinal bacterium could help prevent them from getting them again and reduce the “yo-yo” effect

The hardest part of a diet often comes when the diet seems over. The scale has dropped, clothes are less tight, the body has changed its rhythm. Then, however, the less talked about section begins: the one in which the weight tries to come back up, slowly or quickly, as if the body had a memory of the point from which it started and wanted to take it back with interest. In that passage, delicate and very inglorious, comes a name that seems to have come out of a laboratory rather than a normal conversation: Akkermansia muciniphila.

It is a bacterium that lives naturally in the human intestine, in contact with the layer of mucus that lines the intestinal wall. In healthy people it can represent a significant portion of the microbiota, often indicated at around 3-5% of the intestinal microbial community, although its presence varies greatly from individual to individual. In several studies, a link has been observed between lower levels of Akkermansia muciniphila and metabolic conditions such as obesity and type 2 diabetes. Hence the growing interest: to understand whether this bacterium can become an ally even after losing weight, when the problem becomes maintaining the result without regaining the lost weight.

The study

A new study published in Nature Medicine tried to test this hypothesis on 90 adults with overweight or obesity, with an average age of about 52 years. The experiment, conducted in the Netherlands by a research group linked to the clinical and university area of ​​Maastricht, used a particular form of the bacterium: pasteurized Akkermansia muciniphila MucT. Translated into practical life: a daily supplement containing bacteria inactivated by heat, therefore without live microorganisms ready to colonize the intestine as is often imagined when talking about probiotics.

Participants first followed an eight-week low-calorie diet, designed to achieve significant weight loss. The study states a goal of at least 8% of body weight and, according to the university’s report, the average initial loss was about 11 kilos. At that point the really interesting phase from a metabolic point of view began: 24 weeks of healthy eating, without the rigidity of a strict diet, with one group assigned to the daily supplement of pasteurized Akkermansia muciniphila and the other to the placebo.

The difference was seen precisely in the weight recovery. Those who took the bacterium gained on average 1.2 kilos, compared to 3.2 kilos in the placebo group. Expressed as a percentage of the weight lost in the first phase, the percentage recovered was equal to 13.6% in the Akkermansia group and 32.9% in the control group. A distance which, in a small study, must be read with caution, but which remains clear enough to deserve attention.

The most concrete fact is this: the supplement seems to have helped some people better maintain the weight loss they have already achieved, without replacing diet, movement and daily habits. According to the researchers’ statement, approximately 40% of participants who received Akkermansia even continued to lose weight during the maintenance phase, a much less frequent finding in the placebo group.

The role of the microbiota in weight maintenance

Gaining weight back after a diet is often described as a matter of will, almost as if it were a moral test. Biology, however, works more stubbornly. After weight loss, the body may change hunger, energy expenditure, sugar management, hormonal signals and use of reserves. This is why maintenance is one of the most difficult phases in the journey against overweight and obesity. And it is precisely there that the intestinal microbiota is becoming an increasingly popular research area.

In the group that took Akkermansia muciniphila, the researchers also observed better preservation of insulin sensitivity, that is, the ability of cells to respond to insulin and absorb glucose from the blood efficiently. It is an important detail because it concerns blood sugar regulation and metabolic risk, especially in people with overweight, obesity or a predisposition to type 2 diabetes.

The authors hypothesize multiple possible mechanisms. Part of it may involve how the body sheds energy through feces. Another could pass from adipose tissue, where signals compatible with lower inflammatory activity and more active metabolism have been observed. The picture, however, remains open. To put it carefully: the bacterium appears to move something in the system, but exactly how it does so requires longer and more focused studies.

Limitations of the study and what we really know

The temptation, when faced with such results, is to immediately transform Akkermansia muciniphila into the new magical name for weight loss. It would be the usual mistake, only with a more difficult word to pronounce. The study is randomized, controlled and therefore methodologically sound for a first clinical trial, but involved 90 people and followed the maintenance phase for six months. A useful time to see a signal, still insufficient to understand what happens over longer periods, in larger groups and in people with different clinical conditions.

During the observed period, no serious side effects related to treatment were reported. This is also an encouraging element, especially since we are talking about a pasteurized form of the bacterium. However, there remains a huge difference between a promising result in a controlled study and generalized over-the-counter pharmacy advice. The same experts consulted by the Science Media Center speak of an interesting test, plausible from a biological point of view, with a modest effect and to be interpreted as a possible complementary strategy, not as an alternative to available therapies or nutritional pathways.

This distinction matters. An Akkermansia muciniphila supplement, even when studied well, makes sense within a context: healthy diet, monitoring, physical activity, medical evaluation when talking about obesity, diabetes, drugs or metabolic conditions. The capsule, by itself, remains a capsule. The human body is more complicated than that, as anyone who has lost weight at least once and then tried to defend that result in real life knows, between work, hunger, sleep, stress, dinner out and the fridge open at eleven at night.

For now, Akkermansia muciniphila brings some small but serious good news: the microbiota could help make the maintenance phase less fragile. Larger, longer studies, closer to everyday life, will be needed. Meanwhile, the bacterium has entered the scene.

You might also be interested in: